Medicine is a high-tech, high-risk, high-input and high-return industry, which has always been the focus of competition in developed countries. With the development of economic globalization, international competition is becoming increasingly fierce. In order to enhance international competitiveness, multinational companies have established a global production and sales network and expanded their market share through large-scale mergers and acquisitions and international capital market operations.
Due to the rapid development of modern biotechnology, it has had a revolutionary impact on the pharmaceutical industry. With the deepening of understanding of difficult diseases and the advent of many new biotechnological drugs, the transformation of traditional industries with biotechnology will greatly change the face of the pharmaceutical industry. Developed countries in the world use capital, technology and market advantages to implement monopoly, and traditional Chinese medicine has launched a new round of competition with developed countries in the field of biotechnology.